Leo Niskanen

A pharmacoepidemiological nested case-control study of risk factors for venous thromboembolism with the focus on diabetes, cancer, socioeconomic group, medications, and comorbidities

Myllylahti, L., Niskanen, L., Lassila, R. & Haukka, J., 1 maj 2024, I: Diabetes & vascular disease research. 21, 3, 13 s., 14791641241236894.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Öppen tillgång

Fil

Development of diabetic macular oedema shows associations with systemic medication - An epidemiological study

Loukovaara, S., Korhonen, A., Niskanen, L. & Haukka, J., 2024, I: Acta Ophthalmologica. 102, 4, s. e520-e538 19 s.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Öppen tillgång

Fil

Does the duration of diabetes increase the risk of cancer? A nationwide population-based cohort of patients with new-onset diabetes and a matched reference cohort

Lohi, P., Auvinen, A., Niskanen, L., Partonen, T. & Haukka, J., 1 juni 2024, I: International Journal of Cancer. 154, 11, s. 1940-1947 8 s.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Öppen tillgång

Fil

Empagliflozin Use Is Associated With Lower Risk of All-Cause Mortality, Hospitalization for Heart Failure, and End-Stage Renal Disease Compared to DPP-4i in Nordic Type 2 Diabetes Patients: Results From the EMPRISE (Empagliflozin Comparative Effectiveness and Safety) Study

Langslet, G., Nyström, T., Vistisen, D., Carstensen, B., Grip, E. T., Casajust, P., Tskhvarashvili, G., Hoti, F., Klement, R., Karlsdotter, K., Tuovinen, M., Ofstad, A. P., Lajer, M., Shay, C., Koeneman, L., Farsani, S. F., Niskanen, L. & Halvorsen, S., 2024, I: Journal of diabetes research. 2024, 22 s., 6142211.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Öppen tillgång

Fil

Metabolites and depressive symptoms: Network- and longitudinal analyses from the Finnish Depression and Metabolic Syndrome in Adults (FDMSA) Study

Bernhardsen, G. P., Thomas, O., Mäntyselkä, P., Niskanen, L., Vanhala, M., Koponen, H. & Lehto, S. M., 15 feb. 2024, I: Journal of Affective Disorders. 347, s. 199-209 11 s.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Leo Niskanen

Internationellt och inhemskt samarbete

Fördjupning

A pharmacoepidemiological nested case-control study of risk factors for venous thromboembolism with the focus on diabetes, cancer, socioeconomic group, medications, and comorbidities

Development of diabetic macular oedema shows associations with systemic medication - An epidemiological study

Does the duration of diabetes increase the risk of cancer? A nationwide population-based cohort of patients with new-onset diabetes and a matched reference cohort

Empagliflozin Use Is Associated With Lower Risk of All-Cause Mortality, Hospitalization for Heart Failure, and End-Stage Renal Disease Compared to DPP-4i in Nordic Type 2 Diabetes Patients: Results From the EMPRISE (Empagliflozin Comparative Effectiveness and Safety) Study

Metabolites and depressive symptoms: Network- and longitudinal analyses from the Finnish Depression and Metabolic Syndrome in Adults (FDMSA) Study

Leo Niskanen

Internationellt och inhemskt samarbete

Publikationer

A pharmacoepidemiological nested case-control study of risk factors for venous thromboembolism with the focus on diabetes, cancer, socioeconomic group, medications, and comorbidities

Development of diabetic macular oedema shows associations with systemic medication - An epidemiological study

Does the duration of diabetes increase the risk of cancer? A nationwide population-based cohort of patients with new-onset diabetes and a matched reference cohort

Empagliflozin Use Is Associated With Lower Risk of All-Cause Mortality, Hospitalization for Heart Failure, and End-Stage Renal Disease Compared to DPP-4i in Nordic Type 2 Diabetes Patients: Results From the EMPRISE (Empagliflozin Comparative Effectiveness and Safety) Study

Metabolites and depressive symptoms: Network- and longitudinal analyses from the Finnish Depression and Metabolic Syndrome in Adults (FDMSA) Study